ORCX ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
The Defiance Daily Target 2X Long ORCL ETF (ORCX) is a single-stock leveraged product that tracks Oracle (ORCL) at twice its daily return. Its daily reset, single-stock structure, and differences in leverage and concentrated exposure compared with TQQQ, SSO, and SOXL-related products are the key selection criteria.
What Is the Defiance Daily Target 2X Long ORCL ETF?
It is a single-stock leveraged ETF designed to track twice the daily return of one stock, the software company Oracle (ORCL). It uses derivatives to reflect Oracle's short-term price moves in amplified form, and its exposure is reset on a daily basis.
It suits active traders who want to place a leveraged bet on the short-term direction of Oracle alone and who are willing to accept very high risk.
It is a passive (index-tracking) ETF managed by Defiance.
How Does the Defiance Daily Target 2X Long ORCL ETF Invest?
| Item | Details |
|---|---|
| Underlying Stock | Oracle (ORCL) |
| Management Style | Passive (daily leverage) |
| Leverage | 2x daily return |
| Dividend Frequency | None |
| Expense Ratio | 1.31% |
The fund uses derivatives to build exposure that tracks twice the daily return of Oracle (ORCL), and it resets its leveraged exposure every day. Because of the daily reset structure, a prolonged period of high volatility produces a compounding effect that causes cumulative returns to diverge significantly from simply twice the stock's return. The fund is also concentrated in a single stock, which makes it extremely risky.
- Daily 2x leverage on a single stock, Oracle
- Leverage structure that resets every day
Defiance Daily Target 2X Long ORCL ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $223.2M, and the expense ratio is 1.31% per year.
Compared with investing directly in Oracle without leverage, the main points of comparison are the leverage multiple, the daily reset, and single-stock concentration.
Defiance Daily Target 2X Long ORCL ETF Performance and Trends
Single-stock leveraged products reflect the underlying stock's moves in amplified form, so they typically deliver large gains on up days and large losses on down days. Oracle is sensitive to cloud and artificial intelligence demand and to earnings, and its volatility is high, so the leverage effect can be even more pronounced.
Fund flows into and out of single-stock leveraged products vary sharply with demand for short-term directional bets, and short-term trading money sometimes flows in when the underlying stock's momentum strengthens. It is also worth noting that performance can differ greatly depending on the stock's volatility and its earnings releases.
Defiance Daily Target 2X Long ORCL ETF Pros and Cons
The potential for short-term leveraged gains is both its strength and its risk, and the compounding effect of the daily reset, single-stock concentration, and unsuitability for long-term holding are key considerations.
💪 Key Strengths
⚠️ Points to Watch
Defiance Daily Target 2X Long ORCL ETF Alternative ETFs and Related Products
To invest directly in the underlying stock without leverage, Oracle (ORCL) shares themselves are the direct substitute, and to diversify across the software industry, products such as IGV are also worth comparing. For exposure to the technology sector as a whole, products such as VGT can also be considered. The three products shown in the table, TQQQ, SSO, and SOXL, are leveraged equity index products that track an index, so their underlying assets differ from this product, which bets on a single stock. This ETF is differentiated by its structure of tracking Oracle, a single stock, at twice its daily return.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| ProShares UltraPro QQQ 3x Shares | $62.01 | -10.5% | $35.8B | 0.78% | 0.78% | +7.8% | |
| Direxion Daily Semiconductor Bull 3X ETF | $77.05 | -24.8% | $24.4B | 0.75% | 0.12% | +62.6% | |
| ProShares Ultra QQQ 2x Shares | $82.59 | -6.9% | $14.2B | 0.89% | 0.15% | +11.6% | |
| ProShares Ultra S&P500 2x Shares | $67.67 | -3.6% | $8.8B | 0.84% | 0.7% | +16.6% | |
| Direxion Daily S&P 500 Bull 3X ETF | $270.35 | -5.4% | $7.1B | 0.84% | 0.54% | +21.6% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| United States Lime & Minerals Inc | 0.64% | $111.61 | -2.0% | $3.2B | 23.9 | 0.22% | |
| United States Brent Oil Fund LP | 0.33% | $71.39 | +0.9% | $0.0M | - | - | |
| First American Financial Corp | 0.09% | $63.82 | +0.2% | $6.5B | 9.0 | 3.64% |
Defiance Daily Target 2X Long ORCL ETF Investor Checkpoints
These are the points to review before investing in ORCX. Short-term leveraged gains are attractive, but amplified losses, single-stock concentration, and the compounding effect and unsuitability for long-term holding need to be confirmed in advance. It is best to approach the fund only after fully understanding its leveraged, single-stock structure.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| ⚡ Leverage | Review the daily leverage multiple and what it means | 2x daily |
| 🎯 Single Stock | Review the risk of concentration in Oracle alone | Single-stock concentration |
| 🔁 Daily Reset | Review the compounding effect and long-term divergence | Reset every day |
| ⚠️ Risk Management | Review your stop-loss criteria and holding period | Short term, essential |
When Oracle's share price falls, amplified losses, the compounding effect of the daily reset, and single-stock concentration are the main drivers of performance, and the fund is fully exposed to one company's earnings and negative news. Leveraged single-stock products are not suited to long-term holding and carry a high risk of principal loss.
It is a suitable candidate for risk-tolerant traders who want to place a leveraged bet on the short-term direction of Oracle alone. For investing without leverage, consider Oracle shares or products such as IGV, and for a short-term leveraged bet, it is advisable to choose this product only after fully understanding its structure.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 10, 2026.